Search

Your search keyword '"Darling, Tamarand L."' showing total 41 results

Search Constraints

Start Over You searched for: Author "Darling, Tamarand L." Remove constraint Author: "Darling, Tamarand L."
41 results on '"Darling, Tamarand L."'

Search Results

2. Defining the risk of SARS-CoV-2 variants on immune protection

4. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

7. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

8. Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters.

10. An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo

11. The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2

12. A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters

14. Mucosal vaccine-induced cross-reactive CD8+T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection

15. mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19

17. THE EFFECT OF THE MEASLES, MUMPS AND RUBELLA VACCINE ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN PERSONS RECEIVING A SARS-COV-2 mRNA VACCINE

18. The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2

19. Defining the risk of SARS-CoV-2 variants on immune protection

20. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis

21. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2

22. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters

23. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

24. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

25. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

26. A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants

27. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection

28. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

31. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron variants in mice and hamsters.

32. The Highly Conserved Stem-Loop II Motif Is Dispensable for SARS-CoV-2.

33. Barcoded SARS-CoV-2 viruses define the impact of time and route of transmission on the transmission bottleneck in a Syrian hamster model.

34. A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.

35. Characterization of the SARS-CoV-2 BA.5.5 and BQ.1.1 Omicron Variants in Mice and Hamsters.

36. The highly conserved stem-loop II motif is dispensable for SARS-CoV-2.

37. The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2.

38. A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants.

39. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protection.

40. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.

41. 6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities.

Catalog

Books, media, physical & digital resources